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BRIEF REPORT

Race, Ethnicity, Neighborhood Characteristics,
and In-Hospital Coronavirus Disease-2019 Mortality
Jianhui Hu, PhD,* Christie M. Bartels, MD, MS,†‡ Richard A. Rovin, MD,§ Laura E. Lamb, PhD,∥¶
Amy J.H. Kind, MD, PhD,†#** and David R. Nerenz, PhD*

Background: Despite many studies reporting disparities in coronavirus disease-2019 (COVID-19) incidence and outcomes in Black
and Hispanic/Latino populations, mechanisms are not fully understood to inform mitigation strategies.
Objective: The aim was to test whether neighborhood factors beyond individual patient-level factors are associated with in-hospital
mortality from COVID-19. We hypothesized that the Area Deprivation Index (ADI), a neighborhood census-block-level composite
measure, was associated with COVID-19 mortality independently of
race, ethnicity, and other patient factors.
Research Design: Multicenter retrospective cohort study examining
COVID-19 in-hospital mortality.
Subjects: Inclusion required hospitalization with positive SARSCoV-2 test or COVID-19 diagnosis at three large Midwestern academic centers.
Measure(s): The primary study outcome was COVID-19 in-hospital
mortality. Patient-level predictors included age, sex, race, insurance,
body mass index, comorbidities, and ventilation. Neighborhoods
were examined through the national ADI neighborhood deprivation
rank comparing in-hospital mortality across ADI quintiles. Analyses
used multivariable logistic regression with ﬁxed site effects.
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Results: Among 5999 COVID-19 patients median age was 61 (interquartile range: 44–73), 48% were male, 30% Black, and 10.8% died.
Among patients who died, 32% lived in the most disadvantaged quintile
while 11% lived in the least disadvantaged quintile; 52% of Black, 24%
of Hispanic/Latino, and 8.5% of White patients lived in the most disadvantaged neighborhoods. Living in the most disadvantaged neighborhood quintile predicted higher mortality (adjusted odds ratio: 1.74;
95% conﬁdence interval: 1.13–2.67) independent of race. Age, male
sex, Medicare coverage, and ventilation also predicted mortality.
Conclusions: Neighborhood disadvantage independently predicted
in-hospital COVID-19 mortality. Findings support calls to consider
neighborhood measures for vaccine distribution and policies to
mitigate disparities.
Key Words: health disparities, epidemiology, health policy, socioeconomic factors, housing and health
(Med Care 2021;59: 888–892)

R

acial and ethnic disparities in coronavirus disease-2019
(COVID-19) incidence and outcomes have been extensively documented.1–4 Black and Hispanic/Latino populations have been particularly hard-hit.5 Mechanisms
responsible for these disparities are not fully understood, although disproportionate risks borne by these populations as a
reﬂection of long-standing structural and systemic inequities
likely play a large role.3,5–7 Increasing awareness of such
structural factors has driven calls for new approaches to
mitigate disparities, including the use of small area-level indices of socioeconomic disadvantage (ie, “neighborhood
disadvantage”) as a means to identify, respond to and, ultimately, equitably allocate COVID-19-related resources.8
However, it remains unclear if neighborhood-level factors are themselves a risk factor for COVID-19 mortality.4,7
Patient-level characteristics have been well studied, but less
attention has been paid to neighborhood characteristics as
reasons for higher COVID-19 mortality rates. Experiences of 2
identical individuals with COVID-19 might differ depending
on where they live. For example, high-density housing,6 or
more frequent or crowded grocery trips,9 affect the likelihood
of coronavirus exposure for low-income neighborhoods separate from the living conditions of any individual. Accuracy and
timeliness of information about COVID-19,10 and the ability to
be screened and take appropriate precautions,3 could also be
inﬂuenced by neighborhood characteristics. Ethical justiﬁcation of using neighborhood-level metrics for COVID-19
Medical Care
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resource allocation to mitigate disparities would be strengthened if neighborhood disadvantage itself independently predicted risk of COVID-19 mortality.
Neighborhoods can be characterized many ways using
census and other publicly available data. One potentially useful
metric is the Area Deprivation Index (ADI),11 a measure that
combines 17 speciﬁc indicators (eg, poverty, housing, education, and employment) into an index of disadvantage. The ADI
is freely available to the public through the Neighborhood
Atlas11,12 and has been proposed by thought leaders as a
candidate metric for COVID-19 resource allocation.8 The ADI
has proven useful in a range of health disparities studies.13,14
In this study, we used data from 3 large diverse health
systems in Michigan and Wisconsin to examine the effects of
ADI on in-hospital mortality of COVID-19 patients.

Race, Neighborhood, and COVID-19 Mortality

mortality and predictors changed with additional variables, we
report a series of “stepwise” regression models. Signiﬁcance
was set at P < 0.05; all tests were 2-sided. Sensitivity analysis
compared patients who died to those discharged alive. Analyses were conducted using STATA/SE version 16.1 (StataCorp, LLC, College Station, TX).

RESULTS
Table 1 shows that among 5999 patients with COVID19 median age was 60 years (18–103; interquartile range
(IQR): 44–73), 2858 (47.7%) were male, 1127 (18.8%) were
TABLE 1. Characteristics of COVID-19 Patients by Discharge
or Last Hospital Status
Patients, n (%)

METHODS
This retrospective, observational, cohort study used electronic health record data from 3 large hospital systems: Aurora
Health (Milwaukee, WI), Henry Ford Health Systems (Detroit,
MI), and University of Wisconsin Hospital and Clinics (Madison, WI). Adult patients (18 y old or above) who were hospitalized with conﬁrmed SARS-CoV-2 or diagnosis of COVID-19
between February and June 2020 were included. National ADI
data were obtained through the Neighborhood Atlas,12 from
University of Wisconsin-Madison School of Medicine and
Public Health. IRB approvals or exemptions were obtained for
each entity for pooled analysis of limited data.
Data included patient sociodemographics (age, sex, selfreported race/ethnicity Black, White, or Hispanic/Latino from
the electronic health record), primary insurance (Medicare,
Medicaid, commercial, other, or uninsured), comorbidities,
body mass index (BMI) at admission, mechanical ventilator
use, and discharge disposition. Age was divided into 7 groups:
18–39, 10-year-age groups up to 89, and 90 years and above.
BMI was classiﬁed as underweight, normal weight, overweight, and 3 classes of obesity. Comorbidities including hypertension, lung disease, heart disease, diabetes, and
neurological disease were assessed at admission and any encounters the prior year. Patient addresses were geocoded and
assigned an ADI national rank according to their residential
census block group. Higher ADI rank indicates more disadvantage. Analyses used ADI rank quintiles.
Our outcome, in-hospital mortality, was deﬁned by
patient status at discharge or last hospital observation.
We ﬁrst compared patient characteristics between those
who did and did not die during hospitalization. We also
compared patient characteristics and in-hospital mortality by
race and ethnicity (Black, White, Hispanic/Latino, and other
race). Categorical variables were compared using the χ2 test
or the Fisher exact test. Logistic regressions with site ﬁxed
effects were used to evaluate the association between patient
characteristics and in-hospital mortality. Variables in bivariate analyses with P < 0.1 were included in multivariate
logistic regression models to determine independent predictors of mortality. Collinearity and multicollinearity were
assessed using the Spearman rank correlation and variance
inﬂation factors. To examine how relationships between
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

All
Alive
Patient Characteristics* (n = 5999) (n = 5354)
Age, years
18–39
40–49
50–59
60–69
70–79
80–89
90+
Sex: male
Race and ethnicity
Non-Hispanic White
Black
Hispanic/Latino
Other
Missing
ADI national rank:
quintile
First (1–20): least
disadvantaged
Second (21–40)
Third (41–60)
Fourth (61–80)
Fifth (81–100)
Missing
Primary insurance
Medicare
Medicaid
Commercial
Other
Uninsured
Ventilator use: any
BMI
Underweight (< 18.5)
Normal (18.5–25)
Overweight (25–30)
Class 1 obesity (30–35)
Class 2 obesity (35–40)
Class 3 obesity ( ≥ 40)
Missing
Comorbidities
Hypertension
Lung disease
Heart disease
Diabetes
Neurological disease

1157
761
1047
1172
916
654
292
2858

(19.3)
(12.7)
(17.5)
(19.5)
(15.3)
(10.9)
(4.9)
(47.7)

2392
1765
1127
447
268

(39.9) 2076 (38.8) 316
(29.4) 1538 (28.7) 227
(18.8) 1080 (20.2) 47
(7.5)
410 (7.7)
37
(4.5)
250 (4.7)
18

629 (10.5)

1145
741
1000
1051
736
483
198
2486

(21.4)
(13.8)
(18.7)
(19.6)
(13.8)
(9.0)
(3.7)
(46.5)

Died
(n = 645)

556 (10.4)

12
20
47
121
180
171
94
372

P

< 0.001
(1.9)
(3.1)
(7.3)
(18.8)
(27.9)
(26.5)
(14.6)
(57.8) < 0.001
< 0.001
(49.0)
(35.2)
(7.3)
(5.7)
(2.8)
< 0.001

73 (11.3)

1204
1152
996
1495
523

(20.1) 1112 (20.8) 92 (14.3)
(19.2) 1029 (19.2) 123 (19.1)
(16.6) 921 (17.2) 75 (11.6)
(24.9) 1289 (24.1) 206 (31.9)
(8.7)
447 (8.4)
76 (11.8)

2433
821
1500
306
930
872

(40.6) 1916 (35.9) 517
(13.7) 773 (14.5) 48
(25.0) 1435 (26.9) 65
(5.1)
298 (5.6)
8
(15.5) 923 (17.3)
7
(14.5) 514 (9.6) 358

135
1126
1537
1150
696
675
680

(2.3)
105 (2.0)
30
(18.8) 955 (17.8) 171
(25.6) 1362 (25.4) 175
(19.2) 1059 (19.8) 91
(11.6) 631 (11.8) 65
(11.3) 619 (11.6) 56
(11.3) 623 (11.6) 57

< 0.001
(80.2)
(7.4)
(10.1)
(1.2)
(1.1)
(55.5) < 0.001
< 0.001
(4.7)
(26.5)
(27.1)
(14.1)
(10.1)
(8.7)
(8.8)

2368
1399
2189
1468
1418

(39.5)
(23.3)
(36.5)
(24.5)
(23.6)

(57.2)
(36.1)
(47.4)
(35.8)
(27.4)

1999
1166
1883
1237
1241

(37.3)
(21.8)
(35.2)
(23.1)
(23.2)

369
233
306
231
177

< 0.001
< 0.001
< 0.001
< 0.001
0.016

*All categorical variables were compared using the χ² test or the Fisher exact test.
ADI indicates area deprivation index; BMI, body mass index; COVID-19, coronavirus disease-2019.
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TABLE 2. Characteristics of COVID-19 Patients by Race and Ethnicity
Patient Characteristics

Non-Hispanic White [n (%)]
(n = 2392)

Black [n (%)]
(n = 1765)

Hispanic/Latino [n (%)]
(n = 1127)

Other [n (%)]
(n = 447)

P
< 0.001

Age, years
18–39
40–49
50–59
60–69
70–79
80–89
90+
Sex: male
ADI national rank: quintile
First (1–20) least
disadvantaged
Second (21–40)
Third (41–60)
Fourth (61–80)
Fifth (81–100)
Missing
Primary Insurance
Medicare
Medicaid
Commercial
Other
Uninsured
Ventilator use: any
BMI
Underweight (< 18.5)
Normal (18.5–25)
Overweight (25–30)
Class 1 obesity (30–35)
Class 2 obesity (35–40)
Class 3 obesity ( ≥ 40)
Missing
Comorbidities
Hypertension
Lung disease
Heart disease
Diabetes
Neurological disease

362
198
341
439
449
389
214
1124

(15.1)
(8.3)
(14.3)
(18.4)
(18.8)
(16.3)
(9.0)
(47.0)

264
219
347
422
318
163
32
839

404 (16.9)

(15.0)
(12.4)
(19.7)
(23.9)
(18.0)
(9.2)
(1.8)
(47.6)

56 (3.2)

354
259
236
170
55
41
12
555

(31.4)
(23.0)
(21.0)
(15.1)
(4.9)
(3.6)
(1.1)
(49.3)

50 (4.4)

93
54
74
92
61
43
30
223

(20.8)
(12.1)
(16.6)
(20.6)
(13.7)
(9.6)
(6.7)
(49.9)

0.495
< 0.001

91 (20.4)

699
574
334
204
177

(29.2)
(24.0)
(14.0)
(8.5)
(7.4)

147
174
262
921
205

(8.3)
(9.9)
(14.8)
(52.2)
(11.6)

191
267
308
270
41

(17.0)
(23.7)
(27.3)
(24.0)
(3.6)

114
86
64
64
28

(25.5)
(19.2)
(14.3)
(14.3)
(6.3)

1250
177
554
4
289
312

(52.3)
(7.4)
(23.2)
(5.0)
(12.1)
(13.0)

818
305
464
49
126
351

(46.4)
(17.3)
(26.3)
(2.8)
(7.2)
(19.9)

142
230
334
105
314
123

(12.6)
(20.4)
(29.7)
(9.3)
(27.9)
(10.9)

152
83
100
29
83
59

(34.0)
(18.6)
(22.4)
(6.5)
(18.6)
(13.2)

72
544
643
439
243
223
228

(3.0)
(22.7)
(26.9)
(18.4)
(10.2)
(9.3)
(9.5)

31
268
395
366
268
298
139

(1.8)
(15.2)
(22.4)
(20.7)
(15.2)
(16.9)
(7.9)

8
148
321
252
142
110
146

(0.7)
(13.1)
(28.5)
(22.4)
(12.6)
(9.8)
(13.0)

18
135
134
58
28
24
50

(4.0)
(30.2)
(30.0)
(13)
(6.3)
(5.4)
(11.2)

959
610
1064
540
738

(40.1)
(25.5)
(44.5)
(22.6)
(30.9)

985
606
633
598
358

(55.8)
(34.3)
(35.9)
(33.9)
(20.3)

218
91
301
191
225

(19.3)
(8.1)
(26.7)
(17.0)
(20.0)

146
69
151
105
84

(32.7)
(15.4)
(33.8)
(23.5)
(18.8)

< 0.001

< 0.001
< 0.001

< 0.001
< 0.001
< 0.001
< 0.001
< 0.001

ADI indicates area deprivation index; BMI, body mass index.

Hispanic/Latino, and 1765 (29.4%) Black. Median ADI national rank was 55 (range: 1–100, IQR: 33–83]). Overall, 645
(10.8%) died during hospitalization. Compared with those
alive, more of those who died were older [median (IQR) age,
76 (67–85) vs. 58 (42–70)], male (57.8% vs. 46.5%), Black
(35.2% vs. 28.7%), or White non-Hispanic (49.0% vs.
38.8%). Hispanic/Latino ethnicity was less common among
those who died (7.3% vs. 20.2%). Among patients who died,
32% lived in the most disadvantaged quintile while 11% lived
in the least disadvantaged quintile. A larger proportion also
had comorbid conditions, or required mechanical ventilation
during hospitalization [358 (55.5%) vs. 514 (9.6%)].
Compared with White patients, Black patients were 5 times
more likely and Hispanic/Latino patients almost 3 times more
likely to live in the most disadvantaged neighborhood quintile
[921 of 1765 (52.2%) Black and 270 of 1127 (24.0%) Hispanic/
Latino vs. 204 of 2392 (8.5% White)] as shown in Table 2.
Overall in-hospital death occurred in 13.2% of White patients
(316 of 2392), 12.9% of Black patients (227 of 1765), compared
with 4.2% of (47 of 1127) Hispanic/Latino patients (Table 1).

Table 3 shows the results of multivariable logistic
regressions with ﬁxed effects by site. Complete data on 4767
patients were included in our ﬁnal multivariable logistic
regression (Models 1–4). Collinearity and multicollinearity
were not demonstrated as the Spearman ρ was 0.25 between
race and ADI. The maximum variance inﬂation factors
quantifying any multicollinearity was 3.16 for all right-hand
variables. Race did not initially predict mortality (Table 3
Model 2), and after adding ADI, Black patients had lower
mortality (Model 4 odds ratio (OR): 0.64; 95% conﬁdence
interval (CI): 0.47–0.88) than White patients. Hispanic/Latino
ethnicity did not predict any signiﬁcant mortality difference
compared with White non-Hispanic patients. However, patients who lived in the most disadvantaged neighborhood
quintile were more likely (OR: 1.74; 95% CI: 1.13–2.67) to
die during hospitalization than patients living in the least
disadvantaged neighborhoods. Age greater than 60 years (OR
range: 2.76–28.85, male sex (OR: 1.34; 95% CI: 1.06–1.69),
and ventilator use (OR: 17.38; 95% CI: 13.34–22.66) all
consistently associated with in-hospital death. None of 5

890 | www.lww-medicalcare.com
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TABLE 3. Odds Associating Race, Ethnicity, Neighborhood, Patient Characteristics, and In-hospital Death
Patient Characteristics
(n = 4767)
Age, years
18–39
40–49
50–59
60–69
70–79
80–89
90+
Sex: male
Ventilator use
BMI
Normal (18.5–25)
Underweight (< 18.5)
Overweight (25–30)
Class 1 obesity (30–35)
Class 2 obesity (35–40)
Class 3 obesity ( ≥ 40)
Comorbidities
Hypertension
Lung disease
Heart disease
Diabetes
Neurological disease
Primary insurance
Medicare
Medicaid
Commercial
Other
Uninsured
Race and ethnicity
Non-Hispanic White
Black
Hispanic/Latino
Other
ADI national rank: quintile
First (1–20) least disadvantaged
Second (21–40)
Third (41–60)
Fourth (61–80)
Fifth (81–100)

Model 1 Adj. OR
(95% CI)

Model 2 Adj. OR
(95% CI)

Model 3 Adj. OR
(95% CI)

Model 4 Adj. OR
(95% CI)

1 [Reference]
1.16 (0.48–2.84)
1.88 (0.89–3.97)
2.73 (1.32–5.65)
5.74 (2.69–12.22)
12.98 (5.99–28.14)
26.19 (11.70–58.66)
1.33 (1.05–1.68)
16.96 (13.05–22.05)

1 [Reference]
1.16 (0.47–2.82)
1.85 (0.87–3.89)
2.64 (1.28–5.48)
5.49 (2.58–11.72)
12.09 (5.56–26.29)
23.86 (10.59–53.77)
1.33 (1.05–1.67)
17.31 (13.29–22.54)

1 [Reference]
1.17 (0.48–2.87)
1.92 (0.91–4.05)
2.82 (1.36–5.84)
6.00 (2.81–12.78)
13.64 (6.27–29.65)
28.66 (12.72–64.58)
1.34 (1.07–1.70)
16.87 (12.97–21.94)

1 [Reference]
1.19 (0.48–2.92)
1.89 (0.90–4.01)
2.76 (1.33–5.74)
5.75 (2.70–12.29)
12.71 (5.83–27.70)
28.85 (11.42–58.51)
1.34 (1.06–1.69)
17.38 (13.34–22.66)

1 [Reference]
1.08 (0.61–1.90)
0.86 (0.64–1.15)
0.59 (0.42–0.85)
0.78 (0.52–1.19)
0.81 (0.52–1.26)

1 [Reference]
1.08 (0.61–1.90)
0.84 (0.63–1.14)
0.58 (0.41–0.83)
0.77 (0.50–1.17)
0.80 (0.52–1.25)

1 [Reference]
1.07 (0.61–1.89)
0.85 (0.63–1.14)
0.60 (0.42–0.85)
0.77 (0.50–1.17)
0.79 (0.51–1.23)

1 [Reference]
1.07 (0.61–1.89)
0.83 (0.62–1.12)
0.59 (0.41–0.84)
0.76 (0.50–1.16)
0.79 (0.51–1.23)

0.96
1.08
1.05
1.14
1.30

0.98
1.07
1.02
1.17
1.27

0.94
1.08
1.05
1.12
1.29

0.98
1.06
1.02
1.16
1.24

(0.73–1.26)
(0.84–1.40)
(0.79–1.38)
(0.89–1.46)
(0.98–1.73)

1 [Reference]
0.61 (0.37–0.99)
0.56 (0.37–0.84)
0.47 (0.20–1.12)
0.39 (0.16–0.95)

(0.75–1.30)
(0.83–1.39)
(0.77–1.35)
(0.91–1.50)
(0.96–1.69)

1 [Reference]
0.63 (0.38–1.03)
0.56 (0.37–0.84)
0.47 (0.19–1.12)
0.40 (0.16–0.97)

(0.71–1.24)
(0.83–1.39)
(0.80–1.39)
(0.87–1.45)
(0.97–1.71)

1 [Reference]
0.58 (0.36–0.95)
0.57 (0.38–0.86)
0.44 (0.19–1.06)
0.38 (0.15–0.94)

1 [Reference]
0.78 (0.59–1.03)
0.84 (0.55–1.29)
0.62 (0.38–1.02)

(0.74–1.29)
(0.82–1.38)
(0.77–1.35)
(0.90–1.49)
(0.93–1.65)

1 [Reference]
0.58 (0.35–0.96)
0.57 (0.38–0.87)
0.43 (0.18–1.05)
0.39 (0.16–0.97)
1 [Reference]
0.64 (0.47–0.88)
0.75 (0.48–1.16)
0.63 (0.38–1.03)

1 [Reference]
0.99 (0.66–1.50)
1.38 (0.92–2.05)
1.15 (0.75–1.78)
1.44 (0.97–2.15)

1 [Reference]
0.99 (0.65–1.49)
1.37 (0.92–2.04)
1.21 (0.78–1.88)
1.74 (1.13–2.67)

ADI indicates area deprivation index; BMI, body mass index; CI, conﬁdence interval; OR, odds ratio.

comorbid conditions was associated with death. Compared
with normal BMI, class 1 obesity predicted less mortality
(OR: 0.59; 95% CI: 0.41–0.84). Patients with Medicaid (OR:
0.58; 95% CI: 0.35–0.96) and commercial plans (OR: 0.57;
95% CI: 0.38–0.87) and those uninsured (OR: 0.39; 95% CI:
0.16–0.97) were less likely to die during hospitalization than
Medicare patients.
Sensitivity analysis comparing patients who died and
patients who were discharged alive yielded similar estimates
for all covariates.

DISCUSSION
In this analysis of COVID-19 patients hospitalized at 3
diverse, large Midwestern centers, patients residing in the
highest ADI (most disadvantaged) neighborhoods were signiﬁcantly more likely to die, even after accounting for individual-level risk factors. As others have noted,1–4
individual-level factors of age, race, sex, and several speciﬁc
comorbidities were associated with in-hospital mortality on
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

univariable analyses. In the multivariable analyses, age, sex,
and ADI most signiﬁcantly associated with in-hospital mortality, even accounting for other factors.
The effect of ADI was signiﬁcant, with residents in the
most disadvantaged neighborhoods being at highest risk of
death. While Black and Hispanic/Latino patients were
3–5-fold more likely to reside in such neighborhoods, ADI,
but not race, predicted increased mortality. Our ﬁndings are
consistent with an intensive care unit-based study that reported lower 28-day mortality in people of color, with no
difference in in-hospital mortality, intubation, or intensive
care unit days.15 Moreover, separating ADI from race or
ethnicity as predictors of COVID mortality is informative.
This critically important ﬁnding provides additional scientiﬁc
weight to the increasing calls to use neighborhood disadvantage metrics reﬂective of structural inequities, like the
ADI, for COVID-19 resource allocation.1 Granular geographic
metrics of disadvantage, like the ADI, are a cornerstone
of many global health systems, guiding efﬁcient, effective
www.lww-medicalcare.com
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allocation of scarce resources. Consideration could be given to
using ADI for a similar purpose in the United States.
Limitations include generalizability beyond these
Midwestern, academic centers. Missing data occurred in
n = 1232 observations; missing ADI (n = 523) was more
common in Black patients. Among other factors, this could
represent homelessness which would most likely bias toward
null ﬁndings. Findings should be re-examined in other cohorts with controls for individual income and education beyond neighborhood disadvantage. Fixed effects models
likewise limit analysis of hospital factors or clustering effects.

CONCLUSION
This study adds to the growing body of science and
policy focused on neighborhood contextual factors, like ADI,
and their independent association with key health outcomes.
Finding 50% greater mortality in the most disadvantaged
neighborhood quintile builds upon evidence supporting ADI
as a readily available, policy-applicable means to allocate
COVID-19 vaccine and to implement other strategies toward
mitigating COVID-19 disparities.
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